Mathematical model of dual targetting cancer therapy

data based on melanoma.
Title:  Evolution dynamics of Cancer in response to targetted combination therapy.
The word "cure" actually appears here.    Though it may not apply to BC but the logic used is generally applicable and fairly interesting:
http://elife.elifesciences.org/content/2/e00747


Another article on heterogeneity of breast cancer from serum CTC:

J Intern Med. 2013 Aug;274(2):137-43. doi: 10.1111/joim.12047.

Circulating tumour cells: insights into tumour heterogeneity.

http://www.ncbi.nlm.nih.gov/pubmed/23844916
http://onlinelibrary.wiley.com/doi/10.1111/joim.12047/full


Another  article on the history of "Cell Kill" Adjuvant chemotherapy approaches of last 50 years, and inflammation-cancer link

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691519/

"DIGGING DEEPER: GROWTH PARAMETERS OF SOLID TUMORS CAUSE CHEMOTHERAPY RESISTANCE"